|
1
|
Zhou R, Mo W, Wang S, Zhou W, Chen X and
Pan S: miR-141-3p and TRAF5 network contributes to the progression
of T-cell acute lymphoblastic leukemia. Cell Transplant. 28
(Suppl-1):S59–S65. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Qin X, Zhang MY and Liu WJ: Application of
minimal residual disease monitoring in pediatric patients with
acute lymphoblastic leukemia. Eur Rev Med Pharmacol Sci.
22:6885–6895. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dufinck K, Goossens S, Peirs S, Wallaert
A, Van Loocke W, Matthijssens F, Pieters T, Milani G, Lammens T,
Rondou P, et al: Novel biological insights in T-cell acute
lymphoblastic leukemia. Exp Hematol. 43:625–639. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bongiovanni D, Tosello V, Saccomani V,
Dalla-Santa S, Amadori A, Zanovello P and Piovan E: Crosstalk
between Hedgehog pathway and the glucocorticoid receptor pathway as
a basis for combination therapy in T-cell acutelymphoblastic
leukemia. Oncogene. 39:6544–6555. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lin KT and Wang LH: New dimension of
glucocorticoids in cancer treatment. Steroids. 111:84–88.
2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Scheijen B: Molecular mechanisms
contributing to glucocorticoid resistance in lymphoid malignancies.
Cancer Drug Resist. 2:647–664. 2019.
|
|
7
|
Verbeke D, Demeyer S, Prieto C, de-Bock
CE, De-Bie J, Gielen O, Jacobs K, Mentens N, Verhoeven BM,
Uyttebroeck A, et al: The XPO1 inhibitor KPT-8602 synergizes with
dexamethasone in acutelymphoblastic leukemia. Clin Cancer Res.
26:5747–5758. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jing D, Bhadri VA, Beck D, Thoms JA, Yakob
NA, Wong JW, Knezevic K, Pimanda JE and Lock RB: Opposing
regulation of BIM and BCL2 controls glucocorticoid-induced
apoptosis of pediatric acute lymphoblastic leukemia cells. Blood.
125:273–283. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Roderick JE, Gallagher KM, Murphy LC,
O'Connor KW, Tang K, Zhang B, Brehm M, Greiner DL, Yu J, Zhu LJ, et
al: Prostaglandin E2 stimulates cAMP signaling and re-sensitizes
human leukemia cells to glucocorticoid-induced cell death. Blood:
Aug 5, 2020 (Epub ahead of print).
|
|
10
|
Toscan CE, Jing D, Mayoh C and Lock RB:
Reversal of glucocorticoid resistance in paediatric acute
lymphoblastic leukaemia is dependent on restoring BIM expression.
Br J Cancer. 122:1769–1781. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Meyer LK, Huang BJ, Delgado-Martin C, Roy
RP, Hechmer A, Wandler AM, Vincent TL, Fortina P, Olshen AB, Wood
BL, et al: Glucocorticoids paradoxically facilitate steroid
resistance in T-cell acute lymphoblastic leukemias and thymocytes.
J Clin Invest. 130:863–876. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shi X, Zhao W, Yang Y, Wu S and Lv B:
Salidroside could enhance the cytotoxic effect of L-OHP on
colorectal cancer cells. Mol Med Rep. 17:51–58. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Qi Z, Tang T, Sheng L, Ma Y, Liu Y, Yan L,
Qi S, Ling L and Zhang Y: Salidroside inhibits the proliferation
and migration of gastric cancer cells via suppression of
Src-associated signaling pathway activation and heat shock protein
70 expression. Mol Med Rep. 18:147–156. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li T, Xu K and Liu Y: Anticancer effect of
salidroside reduces viability through autophagy/PI3K/Akt and MMP-9
signaling pathways in human bladder cancer cells. Oncol Lett.
16:3162–3168. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yu G, Li N, Zhao Y, Wang W and Feng XL:
Salidroside induces apoptosis in human ovarian cancer SKOV3 and
A2780 cells through the p53 signaling pathway. Oncol Lett.
15:6513–6518. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhao G, Shi A, Fan Z and Du Y: Salidroside
inhibits the growth of human breast cancer in vitro and in vivo.
Oncol Rep. 33:2553–2560. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li H, Huang D and Hang S: Salidroside
inhibits the growth, migration and invasion of Wilms' tumor cells
through down-regulation of miR-891b. Life Sci. 222:60–68.
2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Qin Y, Liu HJ, Li M, Zhai DH, Tang YH,
Yang L, Qiao KL, Yang JH, Zhong WL, Zhang Q, et al: Salidroside
improves the hypoxic tumor microenvironment and reverses the drug
resistance of platinum drugs via HIF-1α signaling pathway.
EBioMedicine. 38:25–36. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Pelengaris S, Khan M and Evan G: c-MYC:
More than just a matter of life and death. Nat Rev Cancer.
2:764–776. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Fauriat C and Olive D: AML drug
resistance: c-Myc comes into play. Blood. 123:3528–3530.
2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ji W, Zhang W, Wang X, Shi Y, Yang F, Xie
H, Zhou W, Wang S and Guan X: c-myc regulates the sensitivity of
breast cancer cells to palbociclib via c-myc/miR-29b-3p/CDK6 axis.
Cell Death Dis. 11(760)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pyko IV, Nakada M, Sabit H, Teng L,
Furuyama N, Hayashi Y, Kawakami K, Minamoto T, Fedulau AS and
Hamada J: Glycogen synthase kinase 3β inhibition sensitizes human
glioblastoma cells to temozolomide by affecting O6-methylguanine
DNA methyltransferase promoter methylation via c-Myc signaling.
Carcinogenesis. 34:2206–2217. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tan Y, Sementino E, Chernoff J and Testa
JR: Targeting MYC sensitizes malignant mesothelioma cells to PAK
blockage-induced cytotoxicity. Am J Cancer Res. 7:1724–1737.
2017.PubMed/NCBI
|
|
24
|
Ge JC, Yu WD, Li JH, Ma HB, Wang PY, Zhou
YH, Wang Y, Zhang J and Shi GW: USP16 regulates
castration-resistant prostate cancer cell proliferation by
deubiquitinating and stablizing c-Myc. J Exp Clin Cancer Res.
40(59)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yi XL, Lou LP, Wang J, Xiong J and Zhou S:
Honokiol antagonizes doxorubicin resistance in human breast cancer
via miR-188-5p/FBXW7/c-Myc pathway. Cancer Chemother Pharmacol: Feb
5, 2021 (Epub ahead of print).
|
|
26
|
Monga J, Subramani D, Bharathan A and
Ghosh J: Pharmacological and genetic targeting of 5-lipoxygenase
interrupts c-Myc oncogenic signaling and kills
enzalutamide-resistant prostate cancer cells via apoptosis. Sci
Rep. 10(6649)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Sheng Q, Zhang Y, Wang Z, Ding J, Song Y
and Zhao W: Cisplatin-mediated down-regulation of miR-145
contributes to up-regulation of PD-L1 via the c-Myc transcription
factor in cisplatin-resistant ovarian carcinoma cells. Clin Exp
Immunol. 200:45–52. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hirasawa M and Kurita-Ochiai T:
Porphyromonasgingivalis induces apoptosis and autophagy via ER
stress in human umbilical vein endothelial cells. Mediators
Inflamm. 2018(1967506)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Paglin S, Hollister T, Delohery T, Hackett
N, McMahill M, Sphicas E, Domingo D and Yahalom J: A novel response
of cancer cells to radiation involves autophagy and formation of
acidic vesicles. Cancer Res. 61:439–444. 2001.PubMed/NCBI
|
|
31
|
Zhang Y, Zhang Y, Jin XF, Zhou XH, Dong
XH, Yu WT and Gao WJ: The role of astragaloside IV against cerebral
ischemia/reperfusion injury: Suppression of apoptosis via promotion
of P62-LC3-autophagy. Molecules. 24(1838)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kim D, Hwang HY, Kim JY, Lee JY, Yoo JS,
Marko-Varga G and Kwon HJ: FK506, an immunosuppressive drug,
induces autophagy by binding to the V-ATPase catalytic subunit a in
neuronal cells. J Proteome Res. 16:55–64. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jin X, Fang R, Fan P, Zeng L, Zhang B, Lu
X and Liu T: PES1 promotes BET inhibitors resistance and cells
proliferation through increasing c-Myc expression in pancreatic
cancer. J Exp Clin Cancer Res. 38(463)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Robinson AM, Rathore R, Redlich NJ, Adkins
DR, VanArsdale T, Van Tine BA and Michel LS: Cisplatin exposure
causes c-Myc-dependent resistance to CDK4/6 inhibition in
HPV-negative head and neck squamous cell carcinoma. Cell Death Dis.
10:867–879. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lv M, Wang Y, Wu W, Yang S, Zhu H, Hu B,
Chen Y, Shi C, Zhang Y, Mu Q and Ouyang G: C-Myc inhibitor 10058-F4
increases the efficacy of dexamethasone on acute lymphoblastic
leukaemia cells. Mol Med Rep. 18:421–428. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Huang HP, Liu WJ, Guo QL and Bai YQ:
Effect of silencing HOXA5 gene expression using RNA interference on
cell cycle and apoptosis in Jurkat cells. Int J Mol Med.
37:669–678. 2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Capria S, Molica M, Mohamed S, Bianchi S,
Moleti ML, Trisolini SM, Chiaretti S and Testi AM: A review of
current induction strategies and emerging prognostic factors in the
management of children and adolescents with acute lymphoblastic
leukemia. Expert Rev Hematol. 13:755–769. 2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Yu Y, Yu X, Ma J, Tong Y and Yao J:
Effects of NVP-BEZ235 on the proliferation, migration, apoptosis
and autophagy in HT-29 human colorectal adenocarcinoma cells. Int J
Oncol. 49:285–293. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Vazanova A, Jurecekova J, Balharek T,
Marcinek J, Stasko J, Dzian A, Plank L, Zubor P, Racay P and Hatok
J: Differential mRNA expression of the main apoptotic proteins in
normal and malignant cells and its relation to in vitro resistance.
Cancer Cell Int. 18(33)2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S,
Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu
YP, Acevedo-Arozena A, et al: Guidelines for the use and
interpretation of assays for monitoring autophagy (4rd edition).
Autophagy. 17:1–382. 2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Fu Y, Zhang Y, Gao M, Quan L, Gui R and
Liu J: Alisertib induces apoptosis and autophagy through targeting
the AKT/mTOR/AMPK/p38 pathway in leukemic cells. Mol Med Rep.
14:394–398. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Goldar S, Khaniani MS, Derakhshan SM and
Baradaran B: Molecular mechanismsof apoptosis and roles in cancer
development and treatment. Asian Pac J Cancer Prev. 16:2129–2144.
2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Thorburn A, Thamm DH and Gustafson DL:
Autophagy and cancer therapy. Mol Pharmacol. 85:830–838.
2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Long SL, Ren DW, Zhong FF, Niu YN, Qin X,
Mu D and Liu WJ: Reversal of glucocorticoid resistance in acute
lymphoblastic leukemia cells by miR-145. PeerJ.
8(e9337)2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Magani SKJ, Mupparthi SD, Gollapalli BP,
Shukla D, Tiwari AK, Gorantala J, Yarla NS and Tantravahi S:
Salidroside-can it be a multifunctional drug. Curr Drug Metab.
21:512–524. 2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Fan XJ, Wang Y, Wang L and Zhu M:
Salidroside induces apoptosis and autophagy in human colorectal
cancer cells through inhibition of PI3K/Akt/mTOR pathway. Oncol
Rep. 36:3559–3567. 2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhang ZD, Yang W, Ma F, Ma Q, Zhang B,
Zhang YL, Liu YQ, Liu HX and Hua YW: Enhancing the chemotherapy
effect of Apatinib on gastric cancer by co-treating with
salidroside to reprogram the tumor hypoxia micro-environment and
induce cell apoptosis. Drug Deliv. 27:691–702. 2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Yu X, Sun LL, Tan LJ, Wang M, Ren XL, Pi
JX, Jiang MM and Li N: Preparation and characterization of
PLGA-PEG-PLGA nanoparticles containing salidroside and tamoxifen
for breast cancer therapy. AAPS PharmSciTech. 21(85)2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Beesley AH, Firth MJ, Ford J, Weller RE,
Freitas JR, Perera KU and Kees UR: Glucocorticoid resistance in
T-lineage acute lymphoblastic leukaemia is associated with a
proliferative metabolism. Br J Cancer. 100:1926–1936.
2009.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Bhadri VA, Cowley MJ, Kaplan W, Trahair TN
and Lock RB: Evaluation of the NOD/SCID xenograft model for
glucocorticoid-regulated gene expression in childhood B-cell
precursor acute lymphoblastic leukemia. BMC Genomics.
12(565)2011.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Long ZJ, Fang ZG, Pan XN, Fan RF and Lin
DJ: Inhibition of c-Myc by 10058-F4 overcomes imatinib resistance
in chronic myeloid leukemia cells. Chin J Pathophysiol.
30:1590–1594. 2014.
|
|
52
|
Sheikh-Zeineddini N, Safaroghli-Azar A,
Salari S and Bashash D: C-Myc inhibition sensitizes pre-B ALL cells
to the anti-tumor effect of vincristine by altering apoptosis and
autophagy: Proposing a probable mechanism of action for 10058-F4.
Eur J Pharmacol. 870(172821)2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Sayyadi M, Safaroghli-Azar A,
Pourbagheri-Sigaroodi A, Abolghasemi H, Anoushirvani AA and Bashash
D: c-Myc inhibition using 10058-F4 increased the sensitivity of
acute promyelocytic leukemia cells to arsenic trioxide via blunting
PI3K/NF-κB axis. Arch Med Res. 51:636–644. 2020.PubMed/NCBI View Article : Google Scholar
|
